StonvexLoading…
StonvexStonvexStonvexCore line items from IBOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $886.27M | $865.98M | $800.16M | $525.78M |
Operating Income | $520.36M | $508.72M | $523.51M | $382.64M |
Net Income | $412.29M | $409.17M | $411.77M | $300.23M |
EPS (Diluted) | $6.62 | $6.57 | $6.62 | $4.78 |
Total Assets | $16.58B | $15.74B | $15.07B | $15.50B |
Total Liabilities | $13.32B | $12.94B | $12.62B | $13.46B |
Cash & Equivalents | $536.49M | $352.65M | $651.06M | $2.09B |
Free Cash Flow OCF − CapEx | $472.94M | $459.80M | $446.94M | $368.73M |
Shares Outstanding | 62.26M | 62.30M | 62.22M | 62.81M |